1. Market Research
  2. > Healthcare
  3. > Health Services Market Trends

Global Hospital Care Partnering 2010-2017: Deal trends, players and financials

  • March 2017
  • 900 pages
  • Currentpartnering
Report ID: 3021531

Summary

Table of Contents

Summary
Global Hospital Care Partnering 2010-2017: Deal trends, players and financials provides comprehensive understanding and unprecedented access to the hospital care partnering deals and agreements entered into by the worlds leading healthcare companies

Description
Global Hospital Care Partnering 2010 to 2017 provides the full collection of Hospital Care disease deals signed between the world’s pharmaceutical and biotechnology companies since 2010.

Trends in Hospital Care partnering deals
Financial deal terms for headline, upfront and royalty by stage of development
Hospital Care partnering agreement structure
Hospital Care partnering contract documents
Top Hospital Care deals by value
Most active Hospital Care dealmakers

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor’s product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Hospital Care disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Hospital Care deals.

The report presents financial deal terms values for Hospital Care deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

The initial chapters of this report provide an orientation of Hospital Care dealmaking trends.

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in Hospital Care dealmaking since 2010 covering trends by year, deal type, stage of development, technology type and therapeutic indication.

Chapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.

Chapter 4 provides a review of the leading Hospital Care deals since 2010. Deals are listed by headline value. The chapter includes the top 25 most active Hospital Care dealmakers, together with a full listing of deals to which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 5 provides comprehensive access to Hospital Care deals since 2010 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive directory of all Hospital Care partnering deals by specific Hospital Care target announced since 2010. The chapter is organized by specific Hospital Care therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

In addition, a comprehensive appendix is provided with each report of all Hospital Care partnering deals signed and announced since 2010. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in Hospital Care partnering and dealmaking since 2010.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Hospital Care technologies and products.

Report scope
Global Hospital Care Partnering 2010 to 2017 is intended to provide the reader with an in-depth understanding and access to Hospital Care trends and structure of deals entered into by leading companies worldwide.

Global Hospital Care Partnering 2010 to 2017 includes:
- Trends in Hospital Care dealmaking in the biopharma industry since 2010
- Analysis of Hospital Care deal structure
- Access to headline, upfront, milestone and royalty data
- Access to hundreds of Hospital Care deal contract documents
- Comprehensive access to over 3500 Hospital Care deal records
- The leading Hospital Care deals by value since 2010
- Most active Hospital Care dealmakers since 2010

The report includes deals for the following indications: Accident and emergency, Rehabilitation medicine, Surgery, Orthopedics, Aesthetic procedures, Transplantation, plus other hospital care indications.

In Global Hospital Care Partnering 2010 to 2017, available deals and contracts are listed by:
- Headline value
- Upfront payment value
- Royalty rate value
- Stage of development at signing
- Deal component type
- Technology type
- Specific therapy indication

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The Global Hospital care Partnering 2010-2017 report provides comprehensive access to available deals and contract documents for over 1,500 hospital care deals.

Analyzing actual contract agreements allows assessment of the following:
- What are the precise rights granted or optioned?
- What is actually granted by the agreement to the partner company?
- What exclusivity is granted?
- What is the payment structure for the deal?
- How are the sales and payments audited?
- What is the deal term?
- How are the key terms of the agreement defined?
- How are IPRs handled and owned?
- Who is responsible for commercialization?
- Who is responsible for development, supply, and manufacture?
- How is confidentiality and publication managed?
- How are disputes to be resolved?
- Under what conditions can the deal be terminated?
- What happens when there is a change of ownership?
- What sublicensing and subcontracting provisions have been agreed?
- Which boilerplate clauses does the company insist upon?
- Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
- Which jurisdiction does the company insist upon for agreement law?

Global Hospital Care Partnering 2010 to 2017 provides the reader with the following key benefits:
- In-depth understanding of Hospital Care deal trends since 2010
- Access Hospital Care deal headline, upfront, milestone and royalty data
- Research hundreds of actual contracts between Hospital Care partner companies
- Comprehensive access to over 750 links to actual Hospital Care deals entered into by the world’s biopharma companies
- Indepth review of Hospital Care deals entered into by the top 25 most active dealmakers
- Benchmark the key deal terms companies have agreed in previous deals
- Identify key terms under which companies partner Hospital Care opportunities
- Uncover companies actively partnering Hospital Care opportunities

Please note: this report requires certain updates. We have all the information available but require 3 working days business days to complete the process and ensure it is as up-to-date as possible.


Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Ahmad helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Minimally invasive mitral valve repair and replacement procedures. Combined report. European reimbursement report

  • $ 19250
  • Industry report
  • April 2017
  • by Med Tech Reimbursement Consulting

Report presents summary of the reimbursement situation in Europe for all developed or currently under development minimally invasive (transapical approach via mini-thoracotomy) and transcatheter mitral ...

Robotic surgery interventions. European reimbursement report

  • $ 10450
  • Industry report
  • May 2017
  • by Med Tech Reimbursement Consulting

Report presents summary of reimbursement situation for procedures using robotic equipment in European countries. Five the most common robotic surgical procedures are included into report: total prostatectomy ...

Angioplasty of arteries of lower extremities for peripheral artery disease. European reimbursement report

  • $ 10450
  • Industry report
  • April 2017
  • by Med Tech Reimbursement Consulting

Report presents summary of the reimbursement situation in Europe for a group of angioplasty procedures of arteries of lower extremities for peripheral artery disease (plain and drug-eluting balloon angioplasty, ...


ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.